Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
We look forward to working with Ascendis to explore the potential of the TransCon technology platform to reduce the dosing frequency of GLP-1 receptor agonists and other treatments for cardiometabolic diseases.
Plasma B-vitamin and one-carbon metabolites and risk of breast cancer before and after folic acid fortification in the United States
As a relatively new compound, data on 5-Amino-1MQs side effects is still developing
Reconstituting Liraglutide Liraglutide is a bit different from the others because it's typically used at higher doses and injected daily rather than weekly
Vitamin D and the gut microbiome: a systematic review of in vivo studies
US$ 20.40
US$ 21.64
US$ 21.46
US$ 24.38
US$ 29.29
